Treatment of pimary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07

Journal of Clinical Oncology

Volumn 21, Issue 6, 2003, Pages 1044-1049

  Batchelor, Tracy ^a   Carson, Kathryn ^a   O'Neill, Alison ^a   Grossman, Stuart A ^a   Alavi, Jane ^a   New, Pamela ^a   Hochberg, Fred ^a   Priet, Regina ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE;

ADULT; ARTICLE; BRAIN LYMPHOMA; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; IMAGING SYSTEM; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; BRAIN TUMOR; DISEASE FREE SURVIVAL; FEMALE; LYMPHOMA; MALE; MENTAL HEALTH; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; METHOTREXATE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037445256     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.03.036     Document Type: Article

References (32)

1. Statistical Report: Primary Brain Tumors in the United States, 1992-1997. Chicago, IL, Central Brain Tumor Registry of the United States, 2002
2. Eby NL, Grufferman S, Flannelly CM, et al: Increasing incidence of primary brain lymphoma in the US. Cancer 62:2461-2465, 1988
3. Paulus W, Jellinger K, Morgello S: Malignant lymphomas, in Kleihues P, Cavenee WK (eds): Pathology and Genetics. Tumours of the Nervous System. Lyon, France, IARC Press, 1997
4. O'Neill BP, O'Fallon JR, Earle JD, et al: Primary central nervous system non-Hodgkin's lymphoma: Survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 33:663-673, 1995
5. Schultz C, Scott C, Sherman W, et al: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: Initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 14:556-564, 1996
6. Nelson DF, Martz KL, Bonner H, et al: Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23:9-17, 1992
7. Abrey LE, Yahalom J, DeAngelis LM: Relapse and late neurotoxicity in primary central nervous system lymphoma (PCNSL). Neurology 48:A18, 1997
8. Loeffler JS, Ervin TJ, Mauch P, et al: Primary lymphomas of the central nervous system: Patterns of failure and factors that influence survival. J Clin Oncol 3:490-494, 1985
9. Gabbai AA, Hochberg FH, Linggood RM, et al: High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases. J Neurosurg 70:190-194, 1989
10. Glass J, Gruber ML, Cher L, et al: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome. J Neurosurg 81:188-195, 1994
11. O'Brien P, Roos D, Pratt G, et al: Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 18:519-526, 2000
12. Glass J, Shustik C, Hochberg FH, et al: Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD). J Neurooncol 30:257-265, 1996
13. Brada M, Dearnaley D, Horwich A, et al: Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 18:787-792, 1990
14. Boiardi A, Silvani A, Valentini S, et al: Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data. J Neurol 241:96-100, 1993
15. Boiardi A, Silvani A, Pozzi A, et al: Chemotherapy is effective as early treatment for primary central nervous system lymphoma. J Neurol 246:31-37, 1999
16. Brada M, Hjiyiannakis D, Hines F, et al: Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL). Int J Radiat Oncol Biol Phys 40:1157-1162, 1998
17. McAllister LD, Doolittle ND, Guastadisegni PE, et al: Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 46:51-60, 2000
18. Cher L, Glass J, Harsh GR, et al: Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: Preliminary results. Neurology 46:1757-1759, 1996
19. Guha-Thakurta N, Damek D, Pollack C, et al: Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: Response to therapy and quality of life of patients. J Neurooncol 43:259-268, 1999
20. Macdonald DR, Cascino TL, Schold CS Jr, et al: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280, 1990
21. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
22. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, Wiley, 1980, pp 14
23. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34:187-220, 1972
24. SAS Institute Inc.: SAS Proprietary Software Release 8.2 (TS2MO), Cary, NC, SAS Institute Inc., 1999-2001
25. Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002-1006, 1993
26. Schultz C, Scott C, DeAngelis L, et al: Radiation therapy (RT) alone vs. pre-RT chemotherapy (CTX) for the treatment of primary CNS lymphoma (PCNSL): Age matched survival analysis of RTOG 83-15 and RTOG 93-10. Proc Am Soc Clin Oncol 19:159a. 2000 (abstr 617)
27. Abrey LE, Yahalom J, DeAngelis LM: Treatment for primary CNS lymphoma: The next step. J Clin Oncol 18:3144-3150, 2000
28. Henson JW, Yang J, Batchelor T: Vitreous methotrexate concentration after high-dose intravenous therapy for primary central nervous system lymphoma. J Clin Oncol 17: 1329, 1999 (letter)
29. Sharis CM, Hochberg FH, Thornton AF, et al: Is there a role for cranial radiotherapy after primary high dose intravenous methotrexate in primary central nervous system lymphoma? Int J Radiat Oncol Biol Phys 45:327, 1999
30. Cho B, Hochberg F, Loeffler J, et al: Methotrexate reinduction in patients with relapsed primary central nervous system lymphoma. Neuro-Oncology 3:356, 2001
31. Herrlinger U, Schabet M, Brugger W, et al: German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 51:247-252, 2002
32. Ng S, Rosenthal MA, Ashley D, et al: High-dose methotrexate for primary CNS lymphomas in the elderly. Neuro-Oncology 2:40-44, 2000